Bartenstein P - Search Results

1

Are heterobivalent GRPR- and VPAC₁R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?

Lindner S, Rudolf H, Palumbo G, Oos R, Antons M, Hübner R, Bartenstein P, Schirrmacher R, Wängler B, Wängler C. Lindner S, et al. Among authors: bartenstein p. Bioorg Med Chem Lett. 2021 Sep 15;48:128241. doi: 10.1016/j.bmcl.2021.128241. Epub 2021 Jul 2. Bioorg Med Chem Lett. 2021. PMID: 34217827

2

Assessment of perfusion deficit with early phases of [¹⁸F]PI-2620 tau-PET versus [¹⁸F]flutemetamol-amyloid-PET recordings.

Völter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M, Barthel H, Katzdobler S, Palleis C, Franzmeier N, Levin J, Perneczky R, Rauchmann BS, Sabri O, Hong J, Cumming P, Rominger A, Shi K, Bartenstein P, Brendel M. Völter F, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1384-1394. doi: 10.1007/s00259-022-06087-y. Epub 2022 Dec 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 36572740 Free PMC article.

3

Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung.

Schirrmacher E, Schirrmacher R, Thews O, Dillenburg W, Helisch A, Wessler I, Buhl R, Höhnemann S, Buchholz HG, Bartenstein P, Machulla HJ, Rösch F. Schirrmacher E, et al. Among authors: bartenstein p. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2687-92. doi: 10.1016/s0960-894x(03)00538-9. Bioorg Med Chem Lett. 2003. PMID: 12873495

4

Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.

Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rösch F, Schreckenberger M, Wong DF, Cumming P, Gründer G, Bartenstein P. Siessmeier T, et al. Among authors: bartenstein p. J Nucl Med. 2005 Jun;46(6):964-72. J Nucl Med. 2005. PMID: 15937307 Free article.

5

Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases.

Schirrmacher E, Beck C, Brueckner B, Schmitges F, Siedlecki P, Bartenstein P, Lyko F, Schirrmacher R. Schirrmacher E, et al. Among authors: bartenstein p. Bioconjug Chem. 2006 Mar-Apr;17(2):261-6. doi: 10.1021/bc050300b. Bioconjug Chem. 2006. PMID: 16536454

6

18F-labeling of peptides by means of an organosilicon-based fluoride acceptor.

Schirrmacher R, Bradtmöller G, Schirrmacher E, Thews O, Tillmanns J, Siessmeier T, Buchholz HG, Bartenstein P, Wängler B, Niemeyer CM, Jurkschat K. Schirrmacher R, et al. Among authors: bartenstein p. Angew Chem Int Ed Engl. 2006 Sep 11;45(36):6047-50. doi: 10.1002/anie.200600795. Angew Chem Int Ed Engl. 2006. PMID: 16888726 No abstract available.

7

Kit-like 18F-labeling of proteins: synthesis of 4-(di-tert-butyl[18F]fluorosilyl)benzenethiol (Si[18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET.

Wängler B, Quandt G, Iovkova L, Schirrmacher E, Wängler C, Boening G, Hacker M, Schmoeckel M, Jurkschat K, Bartenstein P, Schirrmacher R. Wängler B, et al. Among authors: bartenstein p. Bioconjug Chem. 2009 Feb;20(2):317-21. doi: 10.1021/bc800413g. Bioconjug Chem. 2009. PMID: 19132825

8

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.

Haug A, Auernhammer CJ, Wängler B, Tiling R, Schmidt G, Göke B, Bartenstein P, Pöpperl G. Haug A, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70. doi: 10.1007/s00259-008-1030-8. Epub 2009 Jan 10. Eur J Nucl Med Mol Imaging. 2009. PMID: 19137293

9

Simple and convenient radiolabeling of proteins using a prelabeling-approach with thiol-DOTA.

Wängler C, Schirrmacher R, Bartenstein P, Wängler B. Wängler C, et al. Among authors: bartenstein p. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1926-9. doi: 10.1016/j.bmcl.2009.02.052. Epub 2009 Feb 20. Bioorg Med Chem Lett. 2009. PMID: 19269174

10

Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.

la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P. la Fougère C, et al. Among authors: bartenstein p. Neuroimage. 2010 Jan 15;49(2):1406-15. doi: 10.1016/j.neuroimage.2009.09.048. Epub 2009 Sep 28. Neuroimage. 2010. PMID: 19796699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

705 results

Search Page